Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction  

出　　处：《South China Journal of Cardiology》2011年第4期268-268,共1页岭南心血管病杂志（英文版）

摘　　要：Background The combination of glycoprotein Ⅱb/Ⅲ a inhibitors and heparin has not been compared with bivalirudin in studies specifically involving patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention （PCI）. We compared the two treatments in this patient population.Background The combination of glycoprotein Ⅱb/Ⅲ a inhibitors and heparin has not been compared with bivalirudin in studies specifically involving patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention （PCI）. We compared the two treatments in this patient population.

关 键 词：ST Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction PCI 

分 类 号：R542.22[医药卫生—心血管疾病]